
electroCore, Inc.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
electroCore develops non-invasive vagus nerve stimulation devices, marketed under names like gammaCore, used to treat conditions such as migraine and cluster headache.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Lev Joshua S.CFO and Interim President | Sell | $123K | 12,000at $10.22 | Aug 21, 2026 |
| Lev Joshua S.CFO and Interim President | Sell | $49K | 5,000at $9.88 | Aug 24, 2026 |
| Lev Joshua S.CFO and Interim President | Sell | $28K | 3,000at $9.36 | Aug 25, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ECOR activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.